key: cord-0833530-ic6wdqq6
authors: Shkolnikov, Vladimir M.; Klimkin, Ilya; McKee, Martin; Jdanov, Dmitri A.; Galarza, Ainhoa Alustiza; Németh, László; Timonin, Sergey A.; Nepomuceno, Marília R.; Andreev, Evgeny M.; Leon, David A.
title: What should be the baseline when calculating excess mortality? New approaches suggest that we have underestimated the impact of the COVID-19 pandemic and previous winter peaks
date: 2022-05-06
journal: SSM Popul Health
DOI: 10.1016/j.ssmph.2022.101118
sha: 6f5564945f0f72ccb82904a7dc1c073231dbd377
doc_id: 833530
cord_uid: ic6wdqq6

Excess mortality has been used to measure the impact of COVID-19 over time and across countries. But what baseline should be chosen? We propose two novel approaches: an alternative retrospective baseline derived from the lowest weekly death rates achieved in previous years and a within-year baseline based on the average of the 13 lowest weekly death rates within the same year. These baselines express normative levels of the lowest feasible target death rates. The excess death rates calculated from these baselines are not distorted by past mortality peaks and do not treat non-pandemic winter mortality excesses as inevitable. We obtained weekly series for 35 industrialized countries from the Human Mortality Database in 2000–2020. Observed, baseline and excess mortalities were measured by age-standardized death rates. We assessed weekly and annual excess death rates driven by the COVID-19 pandemic in 2020 and those related to seasonal (predominantly) respiratory infections in earlier years. There was a distinct geographic pattern with high excess death rates in Eastern Europe followed by parts of the UK, and countries of Southern and Western Europe. Some Asia-Pacific and Scandinavian countries experienced lower excess mortality. In 2020 and earlier years, the alternative retrospective and the within-year excess mortality figures were higher than estimates based on conventional metrics. While the latter were typically negative or close to zero in “normal” years without extraordinary epidemics, the alternative estimates were substantial. Cumulation of this usual excess over 2–3 years results in human losses comparable to those caused by COVID-19. Challenging the view that non-pandemic seasonal winter mortality is inevitable would focus attention on reducing premature mortality in many countries. As SARS-CoV-2 is unlikely to be the last respiratory pathogen with the potential to cause a pandemic, such measures would also strengthen global resilience in the face of similar threats in the future.

The total mortality impact of outbreaks of influenza and other respiratory infections are underestimated by statistics on causes of death. This is related both to the complexity of pathological processes and interactions with pre-existing conditions (often cardiovascular) and J o u r n a l P r e -p r o o f also by issues related to diagnosis and cause-of-death coding. Although deaths attributed by official statistics to influenza and respiratory diseases (as the underlying cause) are highly correlated with all-cause mortality fluctuations (Thompson et al. 2009 ; Office for National Statistics 2009), they constitute only a minor part of these fluctuations with a higher share constituted by circulatory diseases (Douglas et al. 1991; Sprenger et al. 1993 ; Office for National Statistics 2012).

This underestimation was also a feature of the SARS-CoV-2 pandemic in 2020 (Armstrong 2021) . The concept of excess mortality has received considerable attention since the start of the pandemic and is now used widely as a metric to quantify the impact of the pandemic, comparing observed deaths with those that would be expected if death rates had remained the same as in previous years (Iacobucci 2021) . It compares week-or month-specific death rates over a year with some baseline mortality level, such as (for example) the five years preceding the year being studied (Schöley 2021; Nepomuceno et al. 2022) . The magnitude of the deviation from previous years is taken as quantifying the deaths that would not have occurred if there had not been a pandemic. Conventional excess mortality measures mortality above what would be expected from mortality in previous years, although this includes periods when mortality was unusually high. Thus, the conventional method makes an implicit assumption (or at least is often interpreted in this way) that death rates during that period were as low as reasonably achievable. Given fluctuations in mortality, both over the course of any given year and in comparison with the same period in previous years, this is clearly not the case. It has the additional effect of normalizing high rates of seasonal mortality that, as we see from international comparisons, are not inevitable. Consequently, there is a need for an alternative approach.

The UK Office for National Statistics, other statistical agencies, and many researchers and data journalists publishing these figures use as a baseline the 5 years from 2015 to 2019 (Office for National Statistics 2021; Kontis et al. 2020 ; see Appendix A for more details). Yet in three of these five years (2015, 2017, and 2018) , many countries faced particularly substantial mortality elevations in winter (Nielsen et al. 2019; Office for National Statistics 2017 , 2019 .

This raises the fundamental question as to what should be regarded as an acceptable or "normal" level of mortality. As seasonal increases in deaths from influenza and other causes are common, should they simply be accepted?

This question has led us to revisit the phenomenon of intra-annual mortality fluctuations especially given that their intensity varies by year and across countries. Specifically, J o u r n a l P r e -p r o o f we have looked at alternative baselines that do not assume that winter mortality excesses are inevitable and therefore implicitly acceptable.

Research on excess mortality has a long tradition in demography and epidemiology (McKee 1989; Rau 2006; Sakamoto-Momiyama 1978) . Despite substantial progress in reducing mortality overall, increased mortality rates at certain times of the year continue to make an important contribution to the annual toll of human deaths in many countries. In the 2010s, substantial increases in winter mortality occurred in many European countries (Nielsen et al. 2019; Hiam et al. 2021 ) and, while these were often associated with influenza epidemics, other factors 1 may have contributed (Marti-Soler et al. 2014; Sartini et al. 2017; Wilkinson et al. 2001; The Eurowinter Group 1997; Keatinge 2002) . Several countries faced life expectancy declines in 2015 followed by a rebound in 2016 and no increase or another decline in 2017 (Ho & Hendi 2018; Leon et al. 2020; OECD 2021; Raleigh 2019) .

The current interest in excess mortality to measure the impact of the pandemic is only the latest example of this method being applied to, for example, epidemics, extreme weather events, famines, and conflicts (Dols & Van Arcken 1946; Ekamper et al. 2017 ). Its advantage is that it avoids problems associated with variability and incompatibility of statistics on causes of death and is accepted by researchers and health authorities as to the most reliable and objective measure of increased mortality caused by the COVID-19 pandemic (Our World in Data 2020; Beaney et al. 2020; The Health Foundation 2020; Leon et al. 2020) and earlier epidemics (Rau 2006; Thompson et al. 2009 ).

In this study, we report an investigation of weekly mortality series from 35 industrialized countries with reliable vital statistics from the beginning of 2000 until the end of 2020. All these countries have experienced intra-annual mortality fluctuations of variable amplitudes, with frequent increases in the winter season. Summer heat-wave mortality peaks are also seen in some. We examine mortality across calendar years and populations and compare levels and patterns of excess mortality in the extraordinary COVID-19 year of 2020 with earlier times. We then employ novel metrics for assessment of excess mortality based on using two alternative mortality baselines that are considered as a target corresponding to the lowest level that has been achieved in a country either in corresponding weeks in recent past years or at another period within the same year. Then we compare the resulting excess mortality estimates with commonly used measures for the period 2005-2020. Our objective is to lay out the various alternative methods that might be used in the future to construct reference or baseline mortality in each country, and in so doing contribute to the emerging debate about whether post-COVID the new normal should be less tolerant of non-pandemic mortality excesses that to an important degree may be avoidable.

In this study, the Short-Term Mortality Fluctuations Database (STMF) of the Human Mortality Database (HMD) served as the prime data source (Human Mortality Database 2021; Németh et al. 2021; . All countries and regions presented in the STMF have reliable vital statistics.

We used the main STMF data file containing death counts and death rates by standardized 7-day weeks according to ISO-8601 (the international standard for the worldwide exchange and communication of date-and time-related data (ISO 8601 2019) and epidemiological weeks in Canada) by year, sex, and broad age groups 0-14, 15-64, 65-74, 75-84, and 85+ . We also used the STMF input country files that provide weekly age-specific death counts by sex and 5-year age groups. For most of the country-year combinations, the 5-year age groups were 0-4, 5-9, 10-14, … . The last age group was 90+ for most countries, and 95+ or 100+ for some countries. Weekly deaths by 5-year age groups were not available for Australia, Canada, England and Wales, Germany, Israel, New Zealand, South Korea, and the USA, each of which uses their own age categories covering broader ranges of ages.

Finally, we used annual data on deaths, death rates, and population counts by singleyear ages from the core HMD. All the data were retrieved from STMF and the core HMD on 5th April 2021.

Although STMF includes 38 countries and regions, we used only 35 of them. Australian data were dropped as they did not include all deaths. We also excluded Luxembourg and Iceland due to low death numbers and large random fluctuations. The analysis included the constituent parts of the UK: England and Wales, Northern Ireland, and Scotland. Twenty STMF series begin from 2000 or 2001 (see Table C1 in Appendix C for more details on data).

Correspondingly, we examined data series from 2000 to 2020. Russian data for 2020 have not yet been delivered (as of 5 th of April 2021) by the Russian statistical agency Rosstat.

J o u r n a l P r e -p r o o f Before estimating excess mortality, we checked the completeness and comparability of weekly mortality data across populations and years. Information about the measures employed has been published elsewhere (Klimkin et al. 2021) but is summarized in the next paragraph.

For the years covered by the HMD core, the annual HMD mortality data are considered a "gold standard". However, the weekly data are mostly labeled as "preliminary" by data providers and are somewhat incomplete by definition. Therefore, we distinguish between two parts of the HMD: STMF and HMD core. The latter provides the final, complete, and detailed data on annual mortality. Updating the HMD core is much slower than updating the STMF.

Consequently, we adjusted the age-specific weekly deaths from STMF for exact compliance with the corresponding annual death counts in the HMD core, as described by Klimkin et al (2021) . In 90% of country-year cases, the adjustment factor was between 0.9998 and 1.0113. In most recent years with missing HMD core data (mostly 2019 and 2020), we adjusted the STMF weekly death counts using adjustment factors from the last year available in the HMD, again as described by Klimkin et al (2021) .

The age compositions of populations under study vary substantially across countries and time. Thus, we used the age-standardized death rate (SDR) as the main mortality measure, based on the 2013 European Standard Population. For 28 countries, the availability of weekly death rates by 5-year age bands enabled a straightforward calculation of weekly SDRs. For precise calculation of SDRs in the remaining seven countries, we applied an indirect calculation procedure that combines the weekly crude death rates by broad age groups with death rates by 5-year-age death rates (Klimkin et al. 2021) . Additional details are given in Appendix A.

The literature suggests two approaches to estimating intra-annual excess mortality (Nicoll et al. 2012; Rau 2006 ). The first is the retrospective one, which has been commonly used to assess excess mortality during the COVID-19 pandemic. This looks at deviations of weekly death rates from a reference level based on the weekly mortality experience averaged over previous years (Kontis et al. 2020; Nicoll et al. 2012; Nielsen et al. 2011; Thompson et al. 2009 ).

Here baseline mortality is defined as predicted mortality for the year in question derived from past mortality series (Nielsen et al. 2019; Nunes et al. 2011 ; Office for National Statistics 2021; Simonsen et al. 2005) . The second is a within-year approach, not used in pandemic situations, which focuses on the variation of mortality across weeks within the index year and is related to seasonality. Here the baseline mortality is defined as mortality during lower mortality weeks (typically in the summer season) of the same year (Andreev & Biryukov 1998; Healy 2003;  J o u r n a l P r e -p r o o f Liddell et al. 2016; Rau 2006; Sakamoto-Momiyama 1978) . The STMF Visualization Toolkit provides simple excess mortality measures implementing both the retrospective and withinyear approaches (Németh et al. 2021) .

Although excess mortality estimates based on the two approaches measure the amount of intra-annual mortality elevation, they make different assumptions. Excess mortality compared to previous years expresses an aversion to any weekly mortality increase relative to recent annual experience. This metric capture rises in all weekly death rates in the index year compared to the past. However, this approach implicitly treats seasonality, especially common winter excesses, as inevitable. In contrast, when excess mortality is measured against mortality within the index year it implies an aversion to excess mortality compared to other weeks within the same year. It is related to seasonality which expresses itself in concave (Northern Hemisphere) or convex (Southern Hemisphere) intra-annual patterns. This metric is insensitive to the annual average level and to how it compares to previous years. In practice, the two types of measures are highly correlated across time and space because the intra-annual mortality elevations contribute both to the contrast with previous years and variation within the index year.

Both the retrospective and the within-year approaches have several variants, each with its strengths and weaknesses.

In the paragraphs below, we present a variant of each one that seeks to define a baseline that represents an achievable target minimum against which different years may be judged.

For an index year , the baseline weekly death rate referring to past years is defined as

where is the week number, ̂ is an estimate of the slope of the linear regression of also Box 1). The use of the second minimum is a commonly used device to reduce the probability of outliers (David, Nagaraja 2003) . 2 According to Eq. 1, for each week w of the index year the baseline weekly death rate ( , ) is equal to the second-lowest value of the observed values for the same week in previous years with an additional shift to include the underlying mortality trend. In this sense, the ( , ) indicates a target level of mortality referring to the lowest weekly death rates in the recent past. The baseline weekly death rates based on the previous minimal values are insensitive to past mortality peaks. This makes an important difference from more conventional metrics involving annual averaging of past weekly death rates.

In calculating the second-minimum baseline it is important to include enough "good" years in which there were no epidemics (Stang et al. 2020) . In the countries under study in 2000-20, winter mortality peaks were seen in 12 of 21 years. We found (analysis not shown here) that a 7-year retrospective period ( = 7) always includes at least two non-epidemic years. However, a 7-year retrospective period reduces the number of index years that can be included in the excess mortality calculation. To relax it, we additionally included in the excess mortality calculation years with data available for at least five previous years ( ≥ 5). Thus, with data series starting at 2000, 2005 is the first possible index year allowing for calculation ( , ). 3

As mentioned earlier, the alternative retrospective baseline, which is derived from low weekly death rates in the past, is considered as a target (desirable) mortality level. In many countries and index years, the empirical second-lowest death rates display random fluctuations across neighboring weeks. However, the target mortality level (by definition) should not differ abruptly between neighboring time points so we have eliminated these fluctuations by smoothing. 4 . The weekly ( , ) were smoothed within every index year between 2005 and 2020 with cubic splines using the smooth.spline function from the R-package stats available in R version 4.0.3. After the smoothing, we additionally adjusted the resulting weekly

SDRs for the exact compliance with the annual averages of the unsmoothed baseline death rates.

The baseline mortality referring to lower mortality weeks within the same (index) year is defined as

where the set Q1 includes 13 weeks (a quarter-year length) belonging to the lower quartile of ( , ) values in year (see also Box 1).

Conventional indexes of the seasonal mortality excess use a fixed calendar frame of the low mortality season (non-winter season) (Healy 2003; Liddell et al. 2016 ). Eq. 2 provides a more flexible definition that is not connected to a fixed range of weeks or months.

The constant (concerning ) baseline death rate ( ) is equal to the lowerquartile of 52 or 53 5 weekly SDR values in year . It determines a lower benchmark of mortality within the index year and highlights the amount of mortality that has to be eliminated to reach perfectly equal weekly SDRs at the average level of the 13 lowest mortality weeks (not necessarily consecutive).

For comparative purposes, we use two retrospective baselines that have been most frequently used in other studies (Box 1) 6 . The first one (r1) corresponds to the conventional averaging of week-specific death rates. The second one (r2) also uses the averaging with additional adjustment for secular trends. Precise mathematical definitions of baselines r1 and r2 which use fixed-effects models are given in Appendix B 7 . The corresponding baseline death rates are denoted 1 ( , ) and 2 ( , ), respectively.

aretro: Weekly death rates that are equal to the second-lowest weekly death rates for the same weeks within the reference period adjusted for the secular trend after smoothing of these 5 Most years under study have 52 weeks. The exceptional 53-week years are 2004, 2009, 2015, and 2020 . Due to the particular start and end days of weeks in Canadian data, this country has 53 weeks in 2014. 6 Summaries of many other possible baseline options can be found elsewhere (Rau 2006; Thompson et al 2009; Schöley 2021) . 7 The weekly fixed effect model is an equivalent of the averaging of death rates over the reference period.

death rates across weeks of the index year. The reference period consists of seven years preceding the index year.

within-year: Weekly death rates that are equal to the average of 13 lowest weekly death rates within the same year.

r1: Weekly death rates that are equal to averages of weekly death rates for the same weeks within the reference period.

r2: Weekly death rates that are equal to averages of weekly death rates for the same weeks within the reference period adjusted for the secular trend.

The excess age-standardized death rate are the differences between the observed and the baseline age-standardized death rates

In the text below, ESDRs calculated from the four baselines are denoted as for the alternative retrospective baseline; for within-year baseline; 1 for comparator baseline r1; 2 for the comparator baseline r2. The annual baseline and observed SDRs, as well as the annual ESDRs, are obtained by averaging the respective weekly SDRs and ESDRs within each year. Such a simple calculation is correct because STMF uses the same population exposure for every week within each calendar year (Human Mortality Database 2021).

Excess death numbers (EDNs) are counts of lives lost due to excess mortality. They were used to measure of absolute losses of human lives. We calculated and by multiplying and , respectively, by population sizes. Variability of EDNs that are defined this way is determined by the intensity of death and population size, but not by population age structures.

To obtain 95% confidence limits for the baseline SDRs, ESDRs, and EDNs, and related variables, we simulated for each sex and country the year-week-country-specific deaths according to the Negative Binomial distributions with parameters equal to empirical death numbers ( , ) and empirical death rates (1000 simulations).

J o u r n a l P r e -p r o o f However, these peaks strongly influence the averaging-based baselines r1 and r2. This is visible in the first ten weeks and weeks 32-33.

In the lower panel of Figure 1 , the index year 2020 shows sharp spring as well as autumn-winter mortality elevations due to the COVID-19 pandemic. In 2015, 2017, and 2018, France also experienced pronounced mortality elevations over the first 13-15 weeks. The general mortality decline in 2013-19 was slower than that in 2003-09. For this reason, the comparator baselines r1 and r2 are closer to each other in the lower than in the upper panel.

Again, the retrospective baseline (aretro) lies below baseline r2. Again, past mortality peaks do not influence the retrospective baseline but influence baselines r1 and r2. Although weekly data, reveals excess mortality in many weeks within years before 2020 (mostly in cold seasons), but for the whole years the totals of week-specific deviations from artificially high baselines r1 and r2 are often negative ( 1 ) or close to zero ( 2 ). 2 (that accounts for the general mortality decline) has substantial positive values in years of particularly strong flu epidemics such as 2015 or (in several countries) 2017-18. and series lie substantially above 2 with values being higher than . By contrast, and indicate mortality excess in many years before 2020. 1 and by about 50/100 000 higher than median 2 . In 2020, median was higher than median by another 50/100 000. However, in "normal years" (such as 2016 or 2019) with less pronounced intra-annual mortality variation, median 1 was negative and median 2 was close to zero. In such years, the gaps between on one side and 1 and 2 on the other were by about 20-40/100 000 greater than the respective gaps in 2020. At the same time, the difference between median values of and in 2016 or 2019 was about the same as the one in 2020.

the other three measures, is somewhat different due to lower temporal variability since the within-year variation often remains high even in "normal" years without major winter peaks. 

In the heat maps (Figure 4) , darker and lighter color columns in the maps indicate years of higher and lower excess mortality (e.g. "normal" and epidemic years). It appears that there are 9 epidemic years out of 16 years observed. Although the year 2020 stands out due to the dramatic increase in mortality during the pandemic, high excess mortality is seen also in earlier years such as 2015 followed by 2012 and 2007.

Darker horizontal rows in the maps mark countries and regions that tend to experience higher excess mortality compared to other countries and regions in many years. There is a distinct geographic pattern of excess mortality with high ESDRs in countries of Eastern Europe.

These are followed by parts of the UK, and countries of Southern and Western Europe.

Overseas countries and Scandinavia tend to experience lower excess mortality.

There are visible similarities between the retro and the within-year maps as one could expect from results presented in the previous section. Despite the similarities, the colors of many country-year cells differ between the retro and the within-year maps. These differences are partly related to a difference between secular trends in and . While Mean losses in 2020 exceeded the 2015-19 annual mean by 2.3 times. Nevertheless, the latter annual mean was still substantial. Therefore, the were cumulating over the five pre-pandemic years, and the total number of excess deaths for the period 2015-19 was (on average) 2.1 fold (CI95% 2.1; 2.2) higher than the total number of excess deaths in 2020. were about three-fold higher than the annual losses in 2020

The maximal in 2015-19 were observed in England and Wales, Italy, France,

Poland, and Spain, the minimal ones in Estonia, Slovenia, Latvia, Lithuania, and New Zealand. In 2020, the corresponding countries were: England and Wales, Italy, France, Poland, and Spain with the highest losses, and Estonia, New Zealand, Latvia, and Finland with the lowest losses.

The magnitude of annual excess death rates and annual absolute losses in pre-pandemic years means that there is an important difference between the alternative metrics and the conventional excess mortality, which was either negative (ESDRr1) or very low positive (ESDRr2) in most of the pre-pandemic years.

This study employed the widely-used concept of excess mortality to assess intra-annual mortality fluctuations between 2000 and 2020 and then to examine fluctuations associated with the SARS-CoV-2 pandemic in 2020 and those caused by epidemics of respiratory infections in earlier years. In a departure from previous practice, we used novel measures of excess morality that are not distorted by past mortality peaks and thus avoid underestimating excess mortality. We used two alternative baselines. Our alternative retrospective baseline was derived from the lowest weekly death rates achieved in previous years and our within-year baseline used an average of 13 lowest weekly death rates within the same year. We believe that these "normative" baselines make more sense from a public health perspective than the "expected mortality" baselines currently used.

The use of our alternative baselines results in excess mortality figures that are substantially higher than estimates based on conventional metrics both in 2020 as well as in earlier years. In "normal" years without particularly pronounced mortality fluctuations, the conventional measures were mostly negative ( 1 ) or very small positive ( 2 ). These values are so low because baselines used in their calculation are artificially shifted upward.

Conventional excess rates 1 and 2 understate the mortality excess because they do not account for mortality trends across years and/or are influenced by past mortality elevations during the reference period. Although in 2000-2020 substantial elevations occurred every second year, the alternative retrospective excess death rates were not downshifted. Our within-year excess death rates tended to be higher than estimates because they implement a "maximalist" desire to liquidate the circumflex pattern of within-year mortality by suppressing all weekly death rates down to minimal within-year levels that are usually observed in the summer season.

Importantly, excess mortality referring to both the alternative retrospective and the within-year baselines was exceptionally high in the pandemic year 2020 but was also substantial in previous years. Thus, even in pre-pandemic years, intra-annual mortality fluctuations contributed more to excess mortality than is often assumed.

There are some limitations to our proposed alternative approach. First, although the novel measures can be calculated from a scalar indicator of mortality (SDR) that maybe also replaced by crude death rate or life expectancy, we do not have a corresponding measurement procedure applicable to vectors of age-specific death rates. Second, the empirical analyses were completed as early as May 2021 using the STMF series as of 5 th of April 2021. At this time, data for 2020 was still incomplete. Subsequently, more data have been added, including weekly mortality in Germany for the period 2000-2015 and in Russia for the year 2000. A conventional analysis of the very high excess mortality in Russia in 2020 is reported elsewhere (Islam et al. 2021; Timonin et al. 2021 ).

The observation that intra-annual mortality fluctuations differ among countries should

give cause for reflection. The appropriate response to the COVID-19 pandemic has been highly contested. Countries took different approaches, in part reflecting their experience of SARS in 2003 as well as the delayed understanding of the major importance of airborne transmission in the spread of COVID-19 (Greenhalgh et al., 2021; Han et al., 2020) . However, in the mainstream and social media, where comment has often been heavily influenced by the ideology of those participating, some, and especially the so-called "lockdown skeptics" (John, 2020) , have frequently invoked the annual toll of influenza-related deaths, asking why governments are responding so intensely to COVID-19 when they fail to do so when influenza epidemics occur (Oliver, 2021) . Leaving aside their often highly selective and misleading use of data, for example arguing incorrectly that the lethality of COVID-19 is comparable to that of influenza (Pekosz, 2020) , perhaps they have a point, even if this is the opposite of what they are advocating.

Before 2020, societies tended to tolerate winter mortality peaks as an inevitable "natural" cyclic phenomenon. Indeed, some critics of restrictions during the pandemic pointed to the failure to act decisively against influenza in the past as a justification for keeping society open and argued that we should move to treating COVID-19 "just like the flu" (Hayne, 2021; Javid, 2021) . Indeed, one adviser to the British government said "in a bad flu season, 200-300 die a day over winter and nobody wears a mask or socially distances, that's perhaps a right line to draw in the sand" (Gallagher, 2022) . However, this argument can be turned on its head. The potentially avoidable character of a large fraction of seasonal influenza deaths is underlined by the fact that levels of influenza, and associated mortality, have been extremely low in many countries in winter 2020/21 (Adlhoch et al., 2021; Sullivan et al., 2020) . Now we know that we can reduce seasonal respiratory infections with basic non-pharmacological interventions (Kadambari et al., 2022) , some have suggested that we might continue with some in the future (Kelly, 2020) . Experience of developing interventions to reduce the impact of COVID-19 in 2020

gives a realistic hope that excess mortality from respiratory infections can be reduced greatly in the future. Thus, we should take the frequent occurrence of large numbers of influenza-related deaths more seriously.

SARS-CoV-2 and the influenza virus differ in many ways, especially in their lethality, and it is unrealistic to expect the severe restrictions necessary to curtail the spread of the former to be imposed each year in response to influenza. However, our analysis should challenge the complacency that exists with respect to seasonal influenza. In most countries the public health response, if it exists, is based on vaccination of those at greatest risk, especially older people (Smetana et al. 2018) . A few also vaccinate children with a nasal vaccine, primarily to reduce their role in transmitting the infection to older relatives. Yet as the historical experience with influenza and the contemporary experience with COVID show us, such an approach lacks ambition and has limited impact.

This calls for a renewed effort to understand what might work after the current pandemic to reduce the avoidable toll of deaths from newly emerging viruses such as the SARS-CoV-2, from "conventional" influenza or any other respiratory infection. It is now clear that our understanding of the transmission of COVID-19 was delayed by the failure to convene the necessary multidisciplinary expertise, in particular those with expertise in aerodynamics (Tang et al. 2021) , the methodological challenges in evaluating the role of face coverings in reducing spread from those infected (as opposed to any role in protecting the wearer) (Greenhalgh 2020) , an under-appreciation of the importance of ventilation of indoor spaces (Morawska 2021) , and a failure to recognize the importance of super-spreading events. However, the magnitude of the crisis has created an imperative to address these knowledge gaps, as well as to develop innovative responses such as RNA vaccines, which some believe have potential to address the problems arising from the need for annual influenza vaccination (Freyn et al. 2020) .

A rejection of the complacency that has characterized responses to seasonal influenza would, as we have shown, make an important contribution to reducing premature mortality in many countries. However, as SARS-CoV-2 is unlikely to be the last respiratory pathogen with the potential to cause a pandemic, such measures will also strengthen global resilience in the face of a similar threat in the future. Notes: Countries ordered according to ESDR values in 2020. In the maps, Russia is placed in a separate row since Russian data of 2020 is still (as of 5 April 2021) unavailable. The 7category scales reflect 14.2% percentiles of ESDR distribution by countries and year. The scales differ between ESDRretro and ESDRwy but are the same for males and females. 

the European Influenza Surveillance Network (2021). Very little influenza in the WHO European Region during the 2020/21 season

Influence of influenza epidemics on mortality in Russia

The COVID-19 pandemic and cause of death

Excess mortality: The gold standard in measuring the impact of COVID-19 worldwide

Order Statistics, Third Edition

Food supply and nutrition in the Netherlands during and immediately after World War II

Composition of seasonality of disease

War-related excess mortality in The Netherlands, 1944-45: New estimates of famine-and non-famine-related deaths from national death records

Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. The Lancet

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Endemic Covid: Is the pandemic entering its endgame? : BBC

Face coverings for the public: Laying straw men to rest

Ten scientific reasons in support of airborne transmission of SARS-CoV-2. The Lancet

Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. The Lancet

Excess winter mortality in Europe: a cross country analysis identifying key risk factors

Austerity, not influenza, caused the UK's health to deteriorate. Let's not make the same mistake again

Recent trends in life expectancy across high income countries: retrospective observational study

Short-term Mortality Fluctuations (STMF) data series

Covid-19: UK had one of Europe's highest excess death rates in under 65s last year

Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries

The economic arguments for opening up Britain are well known. But, for me, the health case is equally compelling. Daily Mail

The short-term mortality fluctuation data series, monitoring mortality shocks across time and space

Critics say lockdowns will be more damaging than the virus. Experts say it's a false choice

No, COVID-19 Is Not the Flu

Calculation of week-specific agestandardized death rates from STMF data on mortality by broad age intervals

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study

Winter mortality and its causes

Covid could change our tolerance of flu deaths

Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries

COVID-19: A need for real-time monitoring of weekly excess deaths

Excess winter deaths in 30

European countries 1980-2013: a critical review of methods

Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries

Deaths in winter: can Britain learn from Europe?

Paradigm shift to combat indoor respiratory infection

An open-sourced, web-based application to analyze weekly excess mortality based on the Short-term Mortality Fluctuations data series

Sensitivity analysis of excess mortality due to the COVID-19 pandemic. Population and Development Review -forthcoming

Influenza-related deathsavailable methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe

Excess mortality related to seasonal influenza and extreme temperatures in Denmark

season: should the burden of influenza B be reconsidered?

Excess mortality associated with influenza epidemics in Portugal

Excess winter mortality in England and Wales

Excess winter mortality in England and Wales: 2016 to 2017 (provisional) and 2015 to 2016 (final)

A pandemic primer on excess mortality statistics and their comparability across countries

Trends in life expectancy in EU and other OECD countries: why are improvements slowing? OECD Health Working Papers

Seasonality in human mortality: a demographic approach

Changes in the seasonality of human mortality: a medico-geographical study

Relationship between outdoor temperature and cardiovascular disease risk factors in older people

Robustness and bias of excess death estimates in 2020 under varying model specifications

Impact of influenza vaccination on seasonal mortality in the US elderly population

Influenza vaccination in the elderly

Impact of Influenza on mortality in relation to age and underlying disease

Excess mortality due to COVID-19 in Germany

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses

Covid-19 has redefined airborne transmission

Excess mortality in Russia and its regions compared to high income countries: An analysis of monthly series of 2020. SSM -Population Health

Understanding excess mortality. What is the fairest way to compare COVID-19 deaths internationally?

Estimates of US influenza-associated deaths made using four different methods

Cold comfort. The social and environmental determinants of excess winter deaths in England, 1986-96. The Policy Press and the Joseph Rowntree Foundation

Highlights • Conventional estimates of excess mortality underestimate potentially avoidable losses • We propose metrics based on best weeks in the same and in earlier years • Our alternative metrics estimate higher annual excess mortality in